A AB BS ST TR RA AC CT T Leukocytosis is defined as having a leukocyte count over 10.000/mm3 in adults. Showing a progressive increase during pregnancy, peripheral leukocyte count may rise up to 20.000 -30.000/mm3 at birth. A 32-year-old G2P1 patient whose leukocytosis continues for about 15 years, was referred to our hospital due to a WBC of 35.000/mm3 at gestational week 30. We found out that the patient's mean preconceptional WBC had been 15.000/mm3 and her mean WBC went up to 20.000/mm3 at early pregnancy. The patient was diagnosed with idiopathic leukocytosis by haematology department and LMWH Clexane 0.4 1 1x x1 1 (E En no ox xa ap pa ar ri in n 0.4 ml, Sanofi-Aventis) was given subcutaneously during the course of pregnancy. Her WBC was 16.300/mm3 at postpartum day 10. The patient's WBC was 12.000/mm3 at postpartum week 6 (after using LMWH) and 14.800/mm3 at postpartum week 8. We think that when the results of the two pregnancies are examined in this rarely seen case and chronic idiopathic leukocytosis is monitored together with LMWH, the potential negative effects on maternal, fetal, and neonatal outcomes (due to predisposition to thrombotic process) can be diminished. ing the abdominal ultrasound taken to exclude hepatosplenomegaly (HSM), an image was seen suggesting a 5-mm stone in her gallbladder, but there was no HSM. As her WBC was 23.100/mm 3 in the complete blood count that was done for checking purposes, her medical history was questioned in more detail. By haematology department for a period of approximately 15 years, an exact diagnosis of idiopathic leukocytosis could not be maden. Her family history revealed that her sister had also a high leukocyte count. The peripheral smear performed at the initial visit showed that the leukocyte percentage distribution was within normal limits. In the flow cytometry that was carried out to exclude chronic lymphocytic leukemia (CLL) (as her total lymphocyte count was 5.000/mm 3 ), there were no findings compatible with that condition (CD3, 7, 5, 19, 20, 22, 33, 34, 45) . The results of the Philadelphia chromosome (Ph chromosome) analysis carried out for chronic myeloid leukemia (CML) were reported to be normal. Since no splenomegaly or lymphadenopathy was observed in her radiologic imaging and no infection or pathology to explain the leukocytosis was found, the patient was diagnosed with idiopathic leukocytosis. A low molecule weight heparin (LMWH) plus enoxaparin sodium (Clexane® 0,4 Anti-XaIu/0,4 Ml) 1*1 therapy was started for her.
The patient's early pregnancy screening tests were known to be negative, and there were no findings in her antepartum well-being tests that would suggest gestational diabetes, hypertension, or fetal growth retardation in the course of her pregnancy. At gestational week 39, she was administered a cesarean delivery, due to a previous cesarean section.
The patient gave birth to a healthy baby girl weighing 2950 gram. The patient began LMWH therapy to last six weeks postpartum against thromboembolism prophylaxis. Her WBC was 16.300/mm 3 at postpartum day 10. Because of the JAK2 V617F gene mutation analysis, which was recommended by the hematology department for any myeloproliferative disease, turned out to be negative, bone marrow aspiration and biopsy examination were proposed. The patient did not agree with these procedures. The patient's WBC was 12.100/mm 3 at postpartum week 6 (after using LMWH) and 14.800/mm 3 at postpartum week 8.
DISCUSSION AND CONCLUSION
In adults as having a leukocyte count over 10,000/mm 3 ; leukocytosis can be classified as neutrophilic, lymphocytic, monocytic, eosinophilic, or basophilic depending on its primary and secondary causes. Neutrophilic causes can be classified as false negativity, and with primary and secondary causes. 3 Although pregnancy and delivery are known to be among the causes of neutrophilia, a differential diagnosis should consider secondary causes such as infection, inflammation, stress, heavy exercise, smoking, drug use (e.g., glucocorticoids, epinephrine), Cushing disease, hyperthyroidism, eclampsia, asplenia, heat stroke, and solid tumors; anomalies such as hereditary neutrophilia, myeloproliferative diseases; chronic myeloid leukemia (CML), chronic neutrophilic leukemia (CNL) and polycytemia vera (PV); and primary causes such as leukemoid reactions. [3] [4] [5] [6] [7] The secondary causes were excluded from the differential diagnosis of our patient due to her leukocytosis diagnosis approximately 15 years prior. No findings were encountered in her pathological examination with respect to hepatosplenomegaly (HSM) and lymphadenopathy (LAP) to suggest infection, inflammation or rheumatologic diseases (i.e., rheumatoid arthritis, Crohn's disease and ulcerative colitis). Other parameters such as hematocrit and platelet values were normal in her hemograms. In our genetic, immunological, and hematological investigations towards primary causes, we did not find any splenomegaly, LAP, or genetic condition that can be associated with hereditary neutrophilia that may involve an autosomal dominant inheritance pattern. 7, 8 As for chronic myeloid leukemia, we did not encounter the presence of immature cells in the peripheral smear, Philadelphia chromosome (Ph chromosome), or a low LAP score that can be compatible with CML. 8, 9 We also did not observe Ph chromosome positivity, HSM, or high vitamin B12 and uric acid, which are associated with CML in our patient. 8 The JAK2 V617F gene mutation analysis we carried out to search for any myeloproliferative diseases (e.g., PV) turned out to be negative. 10 The disease is diagnosed with total exclusion of other situations causes leukocytosis and family history. During the diagnosis, it should be shown that there are no infections, rheumatic diseases, inflammatory diseases and other hematological diseases that will lead to leukocytosis from the patient. Peripheric smear, jak-2 mutation, Ph chromosome and bone marrow examination should be performed in terms of excluding hematologic diseases. These tests can be performed immediately in patients with long-standing leukocytosis. The increase in leukocyte count and peripheral spread may be influenced by the gestational process and other tests are not affected by the gestational process.
As the patient did not agree to undergo the bone marrow aspiration and biopsy examination that were proposed upon receiving a negative result from her gene mutation analysis, we diagnosed her with chronic idiopathic leukocytosis. The presence of similar leukocytosis in her sister seemed to support this diagnosis. Although the secondary causes of leukocytosis improved after the targeted treatment, the primary causes, either congenital or idiopathic, prevailed from time to time. 3 Our aim here was to evaluate the antepartum and postpartum results of a pregnant woman with chronic idiopathic leukocytosis in pregnancy where the immune function exhibits changes. Chronic idiopathic leukocytosis is a rare benign condition and does not require treatment. Since there is not enough data related to the effect of disease on the pregnancy, it is thought that pregnancy loss due to thromboembolism is the only possible condition that the patient may have on the fetus and LMWH prophylaxis is given to prevent pregnancy loss. We think that, when the results of the two pregnancies are examined in this rarely seen case, and chronic idiopathic leukocytosis is monitored together with LMWH, the potential negative effects on maternal, fetal, and neonatal outcomes (due to predisposition to thrombotic process) can be diminished.
S So ou ur rc ce e o of f F Fi in na an nc ce e During this study, no financial or spiritual support was received neither from any pharmaceutical company that has a direct connection with the research subject, nor from a company that provides or produces medical instruments and materials which may negatively affect the evaluation process of this study. 
